Business segments and other information
An operating segment is a component (a) that engages in business activities from which it may earn revenues and incur expenses, (b) whose operating results are regularly reviewed by the chief operating decision maker, (in our case, our Interim President and Chief Executive Officer) to make decisions about resources to be allocated to the segment and to assess its performance, and (c) for which discrete financial information is available. The chief operating decision maker utilizes segment operating profit to evaluate operating expenses through a comparison of budget to actual results as well as an analysis of operating expenses as a percentage of revenue. We do not evaluate our operating segments using discrete asset information.
We have three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). Our reportable segments primarily design, manufacture and distribute medical devices primarily used in critical care and surgical applications and generally serve hospitals and healthcare providers. The products of these segments are most widely used in high-acuity emergent procedures and in general and specialty surgical applications.
The following tables present our segment results for the years ended December 31, 2025, 2024 and 2023:
 2025
 AmericasEMEAAsiaSegment Total
Net revenues$1,279,197 $472,411 $241,105 $1,992,713 
Cost of goods sold
471,570 229,771 118,086 819,427 
Research and development expenses52,846 64,904 19,397 137,147 
Selling, general and administrative expenses285,552 163,182 87,656 536,390 
Segment operating profit (1)
$469,229 $14,554 $15,966 $499,749 
 2024
 AmericasEMEAAsiaSegment Total
Net revenues$1,156,946 $340,255 $202,345 $1,699,546 
Cost of goods sold
426,678 146,062 69,134 641,874 
Research and development expenses49,004 32,847 18,574 100,425 
Selling, general and administrative expenses254,811 110,407 68,833 434,051 
Segment operating profit (1)
$426,453 $50,939 $45,804 $523,196 
 2023
 AmericasEMEAAsiaSegment Total
Net revenues$1,180,709 $316,972 $214,760 $1,712,441 
Cost of goods sold
449,242 138,460 68,762 656,464 
Research and development expenses48,523 48,932 13,842 111,297 
Selling, general and administrative expenses221,870 95,794 67,686 385,350 
Segment operating profit (1)
$461,074 $33,786 $64,470 $559,330 
(1) Segment operating profit represents income from continuing operations before interest, loss on extinguishment of debt and taxes adjusted to exclude unallocated corporate expenses manufacturing variances other than fixed manufacturing cost absorption variances, restructuring charges, separation costs and impairment charges. See reconciliation of segment operating profit measures for further details.
Year Ended December 31,
202520242023
Reconciliation of segment operating profit measure
Segment operating profit$499,749 $523,196 $559,330 
Other unallocated expenses (1)
243,945 269,350 255,585 
Restructuring charges, separation costs and impairment charges
137,431 17,463 4,224 
Gain on sale of assets and business— — (4,448)
Pension settlement charge (2)
— 132,732 45,244 
Income from continuing operations before interest and taxes
$118,373 $103,651 $258,725 
(1) Other unallocated expenses include expenses within costs of goods sold, research and development and selling, general and administrative costs and primarily consist of manufacturing variances other than fixed manufacturing cost absorption variances and unallocated corporate function expenses.
(2) In 2023, we began the execution of a plan to terminate the Teleflex Incorporated Retirement Income Plan (the "TRIP"), a U.S. defined benefit pension plan. In December 2023, we made payments to eligible participants, beneficiaries and alternate payees who elected the one-time lump sum distribution option offered in connection with the TRIP termination, resulting in the recognition of a pre-tax settlement charge of $45.2 million. In 2024, we purchased a group annuity contract, using TRIP assets, which resulted in the recognition of net pre-tax settlement charges of $132.7 million for the year-ended December 31, 2024.
 Year Ended December 31,
Depreciation and amortization
202520242023
Americas$87,422 $96,825 $87,421 
EMEA56,470 38,140 32,663 
Asia15,051 7,856 7,295 
Corporate (1)
18,795 18,713 20,726 
Consolidated depreciation and amortization$177,738 $161,534 $148,105 
(1)Reflects depreciation and amortization included within other allocated expenses per reconciliation of segment operating profit measure.
Geographic data
The following tables provide total net revenues and total net property, plant and equipment by geographic region for the years ended December 31, 2025, 2024 and 2023 and as of December 31, 2025 and 2024, respectively.
Year Ended December 31,
202520242023
Net revenues (based on selling location):
U.S.$1,181,817 $1,079,343 $1,106,896 
Europe484,734 347,899 330,065 
Asia Pacific218,029 179,567 187,946 
All other108,133 92,737 87,534 
$1,992,713 $1,699,546 $1,712,441 
As of December 31,
Net property, plant and equipment:20252024
U.S.$150,964 $146,955 
Mexico136,428 99,997 
Switzerland
103,951 137 
Czech Republic
48,159 38,605 
Germany
30,027 718 
All other28,752 22,049 
$498,281 $308,461 

Historical Timeline

Fiscal YearFiled
2025Feb 27, 2026Showing above
2024Feb 28, 2025
2023Feb 23, 2024
2022Feb 23, 2023
2021Mar 1, 2022
2020Feb 25, 2021
2019Feb 21, 2020
2018Feb 21, 2019
2017Feb 22, 2018
2016Feb 23, 2017
2015Feb 25, 2016

About Segments Disclosures

Segment disclosures break a company into its reportable operating units, revealing revenue, profit, and asset allocation that consolidated financial statements obscure. Under ASC 280, segments must match how the chief operating decision maker views the business, providing a window into internal management structure and resource allocation priorities.

Key signals: compare segment margins to identify which units drive profitability and which destroy value. Watch for changes in the number of reportable segments — segment aggregation or disaggregation often coincides with strategic shifts or attempts to obscure declining performance. Intersegment elimination patterns reveal internal pricing practices. The reconciliation between segment totals and consolidated figures exposes corporate overhead allocation and unallocated items. Geographic revenue concentration highlights regulatory and currency exposure. Compare segment-level capital expenditure against segment revenue to assess where management is investing for future growth versus harvesting existing assets.